Back
Beam Therapeutics, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
82
BEAM
Beam Therapeutics, Inc.
Last Price:
$31.89
Seasonality Move:
-24.7%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atBeam Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Beam Therapeutics, Inc. has on average historically fallen by 17.7% based on the past 5 years of stock performance.
-
Beam Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Beam Therapeutics, Inc. Stock Undervalued?The current Beam Therapeutics, Inc. [BEAM] share price is $32.05. The Score for BEAM is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
-
BEAM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
Will Beam Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Beam Therapeutics, Inc. has on average historically fallen by 17.7% based on the past 5 years of stock performance.
Beam Therapeutics, Inc. Stock Rating
Buy
82
Beam Therapeutics, Inc. (BEAM)
is a Buy
Is Beam Therapeutics, Inc. overpriced?
-
Beam Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Beam Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com
52-Week Data
52-Week High:
36.44
52-Week Low:
13.53
Prediction Charts
Market Cap:
3.3B
Price in USD:
32.05
Volume:
2.1M
Beta:
1.84
Technical Analysis
SMA50:
25.99
SMA100:
24.67
SMA200:
21.40
52-Wk Change:
37.02%
Stock Predictions
-
Is Beam Therapeutics, Inc. stock public?Yes, Beam Therapeutics, Inc. is a publicly traded company.
-
What is the Beam Therapeutics, Inc. stock quote today?The Beam Therapeutics, Inc. stock price is 32.05 USD today.
-
How to buy Beam Therapeutics, Inc. stock online?You can buy Beam Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-24 | 27.92 | 28.14 | 28.29 | 27.50 |
| Dec-26 | 28.00 | 27.98 | 28.03 | 26.71 |
| Dec-29 | 27.64 | 27.84 | 28.70 | 27.28 |
| Dec-30 | 27.75 | 27.82 | 27.96 | 27.38 |
| Dec-31 | 27.95 | 27.72 | 28.00 | 27.46 |
| Jan-5 | 27.03 | 26.84 | 27.96 | 26.33 |
| Jan-6 | 26.80 | 28.34 | 30.50 | 26.61 |
| Jan-7 | 28.52 | 28.93 | 30.08 | 28.52 |
| Jan-8 | 28.52 | 28.00 | 28.93 | 27.59 |
| Jan-9 | 28.17 | 27.55 | 28.71 | 27.29 |
| Jan-12 | 29.50 | 33.69 | 36.44 | 29.16 |
| Jan-13 | 33.48 | 34.55 | 34.89 | 31.61 |
| Jan-14 | 34.61 | 35.41 | 36.18 | 34.30 |
| Jan-15 | 35.34 | 32.05 | 35.51 | 31.90 |
Beam Therapeutics, Inc. Earnings
Beam Therapeutics, Inc. Earnings Report: Per Share Beam Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Beam Therapeutics, Inc. Forecast Revenue Growth
Beam Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.01 per share.
* Beam Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.